Clostridium Difficile Toxin A/B ELISA

$441.00
Catalog
86-TABHU-E01
The Clostridium difficile (C. difficile) Toxin A/B ELISA is for the qualitative determination of C. difficile toxins A and B in human stool and from cultures of toxin-producing C. difficile strains that were previously cultured from stool samples. For Research Use Only. Not for use in diagnostic procedures.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Sensitivity
Toxin A - 0.132 ng/mL / Toxin B - 0.117 ng/mL
Sizes
96 Wells
Sample Types
Stool
Inc Time Hour
1 hr to 1hr 45 min
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
100
Detection
Colorimetric
The C. difficile Toxin A/B ELISA employs monoclonal antibodies in a sandwich-type method. These monoclonal antibodies against C. difficile toxins A and B are attached to the surface of each well in the microplate. A pipette is used to place a suspension of the stool sample to be examined as well as controls into the well of the microplate together with biotinylated anti-toxin A/B antibodies (Conjugate 1) for incubation at room temperature (20 to 25° C). After washing, streptavidin poly-peroxidase conjugate (Conjugate 2) is added and incubated again at room temperature (20 to 25° C). Any toxins specific to C. difficile present in the sample forms a sandwich complex consisting of immobilized antibodies, toxins, and conjugated antibodies. Unattached streptavidin poly-peroxidase conjugate is removed in a subsequent washing step. After addition of the substrate, the attached enzyme changes the previously colorless solution to blue in the wells that contain bound toxins. Upon addition of the stop solution, the color changes from blue to yellow. The absorbance is proportional to the concentration of toxins A and B present in the sample.

Clostridium Difficile Toxin A/B ELISA

86-TABHU-E01

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

 ALPCO Glucagon ELISA
Spotlight: ALPCO Glucagon ELISA
The ALPCO Glucagon ELISA is for the quantitative determination of glucagon in human EDTA plasma. This assay was developed for ease-of-use and demonstrates superior sensitivity while eliminating cross-reactivity issues present in other commercially-available assays. 
View Now
Accuracy in Calprotectin Testing
Accuracy in Calprotectin Testing
ALPCO’s automated turbidimetric solution for calprotectin testing offers enhanced efficiency without compromising clinical sensitivity or specificity. Clinicians can prioritize endoscopic evaluation for the patients that need it most and quickly put IBS patients on the right treatment path. 
View Now
Clinical Lab on Fecal Calprotectin Testing
Webinar On-Demand: A Clinical Laboratory’s Perspective on Fecal Calprotectin Testing
Join our speaker from Department of Pathology , University of Utah School of Medicine, Dr. Heather Nelson, to discuss how to validate and launch a FDA-approved assay.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.